For the year ending 2025-12-31, MNOV made $409,657 in revenue. -$11,989,983 in net income. Net profit margin of -2926.83%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 409,657 | |||
| Cost of services | 378,606 | |||
| Research, development and patents | 7,154,848 | |||
| General and administrative | 6,159,205 | |||
| Total operating expenses | 13,692,659 | |||
| Operating loss | -13,283,002 | |||
| Interest income | 1,303,792 | |||
| Other expense, net | -12,753 | |||
| Loss before income taxes | -11,991,963 | |||
| Income tax expense | 5,994 | |||
| Net loss | -11,997,957 | |||
| Foreign currency translation adjustments | 7,974 | |||
| Comprehensive loss | -11,989,983 | |||
| Basic EPS | -0.24 | |||
| Diluted EPS | -0.24 | |||
| Basic Average Shares | 49,063,438 | |||
| Diluted Average Shares | 49,063,438 | |||
MEDICINOVA INC (MNOV)
MEDICINOVA INC (MNOV)